<table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl1" position="float"><object-id pub-id-type="doi">10.7554/eLife.18173.006</object-id><label>Table 1.</label><caption><p>Severity of inflammatory cell infiltration of tumors. Excised tumors were fixed, sectioned, and stained with hematoxylin and eosin and blindly scored by a Board Certified pathologist utilizing the severity score for inflammatory cell infiltrates (<xref ref-type="bibr" rid="bib8">Demaria et al., 2001</xref>). Tumor infiltrating lymphocytes and neutrophils were scored for tumors from mice bearing orthotopic MT1A2 breast tumors treated every other day with IgG isotype control (IgG) (n&#160;=&#160;7) or anti-mouse CD47 (CD47) (n&#160;=&#160;6) antibodies. Additional details for this experiment can be found at <ext-link ext-link-type="uri" xlink:href="https://osf.io/g57ch/.">https://osf.io/g57ch/.</ext-link></p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.18173.006">http://dx.doi.org/10.7554/eLife.18173.006</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th colspan="4">Lymphocytic infiltrate</th><th colspan="4">Neutrophilic infiltrate</th></tr><tr><th>Treatment</th><th>Absent</th><th>Minimal</th><th>Moderate</th><th>Brisk</th><th>Absent</th><th>Minimal</th><th>Moderate</th><th>Brisk</th></tr></thead><tbody><tr><td>IgG</td><td>0</td><td>6</td><td>1</td><td>0</td><td>0</td><td>4</td><td>3</td><td>0</td></tr><tr><td>CD47</td><td>0</td><td>5</td><td>1</td><td>0</td><td>0</td><td>1</td><td>3</td><td>2</td></tr></tbody></table></table-wrap>